PodMed – Week of August 29, 2016
This week’s topics include breast density and mammography, genetic analysis and chemotherapy in early breast cancer, reducing sugar for kids, and treating essential tremor. Program notes: 0:32 Reducing sugar consumption in kids 1:35 A third of what kids are currently recommended 2:36 Need to address in children 2:47 Predictive value of breast density in mammography […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - August 27, 2016 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Breast Health Cancer Diet Neurology And Neurosurgery Obesity Pediatrics PodMed Source Type: podcasts
Overview of chemotherapy-induced neurotoxicities
Charles Loprinzi, MD from Mayo Clinic, Rochester, MN discusses neurotoxicities caused by a chemotherapy treatment. Numbness, tingling, shooting, and burning pain can come with the chemotherapy and las...
Author: VJOncology
Added: 08/25/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 25, 2016 Category: Cancer & Oncology Source Type: podcasts
Adjuvant Chemotherapy for Elderly and Frail Patients Part 2
Dr. Rachel Sanborn, Providence Thoracic Oncology Program, discusses using adjuvant chemotherapy for elderly and frail patients. What was seen in particular in the trial performed by NCI Canada, using...
Author: cancergrace
Added: 08/24/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 24, 2016 Category: Cancer & Oncology Source Type: podcasts
Discussing neuropathy with your doctor
Professor Charles Loprinzi of Mayo Clinic, Rochester, MN discusses nerve damage, also know as neuropathy, caused by chemotherapy. It is important to establish that some drugs cause nerve toxicity on a...
Author: PatientPowerEU
Added: 08/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Adjuvant Chemotherapy for Early Stage NSCLC Patients Part 1
Dr. Rachel Sanborn, Providence Thoracic Oncology Program, discusses the reasons behind using adjuvant chemotherapy for early stage NSCLC patients. Clinical studies have shown that adding chemotherap...
Author: cancergrace
Added: 08/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Exploring the link between chemotherapy-induced toxicities
Rachel Gibson, PhD of University of South Australia, Adelaide, Australia explores the links between chemotherapy induced toxicities that would normally be treated in isolation. With chemotherapy induc...
Author: VJOncology
Added: 08/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Advanced Prostate Cancer: Advances in Chemotherapy
Are there new developments in treating advanced prostate cancer with chemotherapy? An expert roundtable featuring Dr. Russell Szmulewitz, Dr. Emmanuel Antonarakis, Malecare Director, Joel Nowak, and m...
Author: patientpower
Added: 08/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 20, 2016 Category: Cancer & Oncology Source Type: podcasts
Changing Strategies in the War on Cancer - Part 2: The Complexities in Manufacturing Highly Potent Anti-Cancer Medicines
For decades, the hallmark of medical treatment for cancer and hematological malignancies has been intravenous cytotoxic chemotherapy. These drugs target rapidly dividing cells, including cancer cells ...
Author: ADCReview
Added: 07/26/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 26, 2016 Category: Cancer & Oncology Source Type: podcasts
How to prepare for your cancer treatment: chemotherapy and surgery
Dr Jalid Sehouli of the Charit Comprehensive Cancer Center, Berlin, Germany, talks about how you can prepare for chemotherapy or surgery. He recommends that 23 weeks prior to treatment, patients sho...
Author: PatientPowerEU
Added: 07/25/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 25, 2016 Category: Cancer & Oncology Source Type: podcasts
"Pre-leukemic clones that survive chemotherapy are linked to a higher risk of leukemia recurrence "
Press brief by Klaus Metzeler, MD of the Ludwig-Maximilians University, Munich, Germany, at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.
Author: VJHemOnc
Added: 06/28/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 28, 2016 Category: Cancer & Oncology Source Type: podcasts
Randy Broad: How I managed the side-effects of my cancer treatment
Randy Broad, a lung cancer survivor and advocate went through a variety of treatments which included chemotherapy, surgery and radiotherapy. In this video he talks about how he managed the side-effect...
Author: PatientPowerEU
Added: 06/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts
Bevacizumab in combination with chemotherapy in metastatic urothelial cancer
Dr. Arjun Balar, MD of NYU Langone Medical Center discusses Bevacizumab in combination with chemotherapy in metastatic urothelial cancer at ASCO 2016
Author: ASCO2016
Added: 06/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 16, 2016 Category: Cancer & Oncology Source Type: podcasts
Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies
The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to the likelihood of recurrence after the initial...
Author: EMJ
Added: 06/10/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 10, 2016 Category: Cancer & Oncology Source Type: podcasts
JAMA Surgery : Preoperative Chemotherapy and Radiation for Borderline Resectable Pancreatic Cancer
Interview with Matthew H. G. Katz, MD, author of Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101 (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 8, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Preoperative Chemotherapy and Radiation for Borderline Resectable Pancreatic Cancer (JAMA Surgery)
Interview with Matthew H. G. Katz, MD, author of Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101 (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 8, 2016 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
